Winning Biotech Investors Through Strategic Partnerships and Trial Innovation

Innovating Autoimmune Treatment with In Vivo CAR-T

How Olon’s fully integrated, end-to-end ADC capabilities drive quality and scale

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Oct. 20, 2025

Drug Fix: US FDA Involved In Astra Zeneca’s Drug Pricing Deal, DOJ’s Off-Label Promotion Policy

Adalvo: Exploring European B2B Pharma’s Next Steps

Lupus Clinical Development Enters a New Era of Innovation

Essential Pharma – Following A Patient First Philosophy

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

Scrip's Five Must-Know Things - Oct. 14, 2025

Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases

Defining the Next Era of Disruption

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.7, 2025

Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao

Scrip's Five Must-Know Things - Oct. 6, 2025

Drug Fix: Government Shutdown’s Impact On US FDA, Pfizer Inks Drug Pricing Deal

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.30, 2025

Scrip's Five Must-Know Things - Sept. 30, 2025

The Generics Bulletin Podcast: Talking with AAM president and CEO John Murphy